Increase transparency across the prescription drug supply chain, including Pharmacy Benefit Managers (PBMs), drug manufacturers, wholesalers, pharmacies, direct-to-consumer platforms, and pharmacy services administrative organizations, to expose opaque pricing practices and ensure affordable prices for patients.
Increase transparency across the prescription drug supply chain, including PBMs and manufacturers.
Occurrences
Evidence
No stored evidence yet.
Assessments
No assessments yet.